| Detected | Trial | Change |
|---|---|---|
| 2026-07-19 | NCT06413706 A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children… |
date change Primary completion moved earlier: 2027-11 -> 2027-02 |
| 2026-07-19 | NCT07223593 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease |
Trial sites expanded: 150 -> 154 locations |
| 2026-07-19 | NCT07392190 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are… |
Trial sites reduced: 185 -> 173 locations |
| 2026-07-19 | NCT07321886 A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without… |
Trial sites reduced: 169 -> 162 locations |
| 2026-07-19 | NCT07287098 A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen… |
Trial sites expanded: 74 -> 78 locations |
| 2026-07-19 | NCT05024045 Study of Oral LOXO-338 in Patients With Advanced Blood Cancers |
Trial completed |
| 2026-07-19 | NCT05024045 Study of Oral LOXO-338 in Patients With Advanced Blood Cancers |
Enrollment reduced: 316 -> 27 participants |
| 2026-07-19 | NCT05024045 Study of Oral LOXO-338 in Patients With Advanced Blood Cancers |
date change Completion moved earlier: 2026-06 -> 2026-04-01 |
| 2026-07-17 | NCT06148272 A Study of LY3971297 in Healthy Participants |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-17 | NCT07654972 A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy |
Recruitment opened |
| 2026-07-17 | NCT06916143 Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made… |
date change Primary completion pushed: 2026-07 -> 2026-08 |
| 2026-07-17 | NCT06916143 Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made… |
date change Completion pushed: 2026-07 -> 2026-08 |
| 2026-07-17 | NCT06817356 A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use… |
Trial completed |
| 2026-07-17 | NCT06817356 A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use… |
date change Completion moved earlier: 2026-08 -> 2026-05-19 |
| 2026-07-17 | NCT07665879 A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity |
Recruitment opened |
| 2026-07-17 | NCT07225556 A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-17 | NCT04088396 A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-17 | NCT04088396 A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old… |
date change Primary completion pushed: 2026-09 -> 2026-10 |
| 2026-07-17 | NCT04088396 A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old… |
date change Completion pushed: 2026-09 -> 2026-10 |
| 2026-07-17 | NCT06982859 A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin… |
overall status: "Recruiting" → "Active Not Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-16 | NCT07707375 A Study of LY4268989 (MORF 057) in Healthy Participants | Phase 1 | Not Yet Recruiting |
| 2026-07-14 | NCT07701083 A Study of Eloralintide (LY3841136) in Healthy Participants | Phase 1 | Not Yet Recruiting |
| 2026-07-13 | NCT07698210 A Study of LY4178256 in Healthy Participants | Phase 1 | Not Yet Recruiting |
| 2026-06-30 | NCT07675057 Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth… | Available | |
| 2026-06-25 | NCT07668336 A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants… | Phase 3 | Not Yet Recruiting |
| 2026-06-24 | NCT07665879 A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity | Phase 1 | Recruiting |
| 2026-06-23 | NCT07662798 A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06876649 | A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib | Chronic Lymphocytic Leukemia | Recruiting |
| NCT06876662 | A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT07438444 | A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2… | Diabetes Mellitus, Type 2 | Recruiting |
| NCT06857942 | A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation… | Psoriasis | Recruiting |
| NCT06864026 | A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in… | Psoriatic Arthritis | Recruiting |
| NCT07218341 | A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT07247084 | A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants… | Obesity | Recruiting |
| NCT07006792 | A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic… | Atopic Dermatitis | Active, Not Recruiting |
| NCT07612267 | A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving… | Lactation | Not Yet Recruiting |
| Phase 3 | |||
| NCT07035093 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and… | Obesity | Recruiting |
| NCT05509777 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease | Crohn's Disease | Recruiting |
| NCT06339008 | A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis… | Perennial Allergic Rhinitis (PAR) | Recruiting |
| NCT06672549 | A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) | Obesity | Recruiting |
| NCT06672939 | A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or… | Obesity | Recruiting |
| NCT06739122 | A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type… | Type 2 Diabetes | Recruiting |
| NCT04844606 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants… | Ulcerative Colitis | Recruiting |
| NCT06119581 | A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT06338995 | A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal… | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | Recruiting |
| NCT06439277 | A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities… | Obesity | Recruiting |
| NCT06937086 | Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With… | Ulcerative Colitis | Recruiting |
| NCT06937099 | Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to… | Crohn's Disease | Recruiting |
| NCT07142954 | Epidemiology and Biomarker Study in Alzheimer's Disease | Alzheimer Disease | Recruiting |
| NCT07157774 | Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated… | Elevated Lp(a) | Recruiting |
| NCT07174336 | A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… | Breast Neoplasms | Recruiting |
| NCT07219966 | A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder | Alcohol Use Disorder | Recruiting |